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Supplemental Experimental Procedures 
 
Animals 
Breeding pairs of brain-derived neurotrophic factor bdnf +/- mice (Ernfors et al., 1994), 
C57BL/6-Tg(ACTB-EGFP)1Osb/J  mice expressing EGFP (Okabe et al., 1997) and 
p75NTR +/- (exon III) mice (Lee et al., 1992) were purchased from the Jackson 
Laboratory (Bar Harbor, ME). BALB/c mouse breeding pairs were purchased from 
Charles River Laboratories (Wilmington, MA). All experimental procedures were 
performed in accordance with the National Institutes of Health guidelines and were 
approved by the Dana-Farber Cancer Institutional Animal Care and Use Committee. 
 
Antibodies and Pharmacological Reagents 
p-Trk (pY490) antibody was made in house (Segal et al., 1996).  Other antibodies were 
obtained as follows: Tiam1 (Santa Cruz); GFP and BDNF (Abcam); p-Akt, Akt, p-
Erk1/2, Erk1/2 (Cell Signaling); TrkB (Chemicon) or chicken anti-TrkB (generous gift 
from Dr. Louis F. Reichardt of University of California, San Francisco) for 
immunostaining; TrkB (for immunoblot), EEA1, α-adaptin, Rac1, cdc42, RhoA and 
BrdU (BD Transduction Laboratories); PI(3,4,5)P3 (Echelon). HRP-conjugated 
secondary antibodies (Zymed); Alexa®  568- conjugated phalloidin, Alexa® 488- and 
Alexa® 546-conjugated secondary antibodies (Molecular Probes). The pharmacological 
reagents K252a, LY294002, U0126, Toxin B and monodansyl cadaverine (MDC) were 
purchased from Calbiochem; BDNF and NT4 from Peprotech. Lipid-modified Sonic 
Hedgehog was a generous gift from Curis. 
 
DNA Constructs and Lentivirus Production 
Tiam1 siRNA lentivirus construct was described previously (Tolias et al., 2005). bdnf 
siRNA and control scrambled sequences were delivered using a lentiviral construct 
pFu6UGW modified from pFUGW (Lois et al., 2002).  Briefly, a U6 promoter-driven 
shRNA cassette with an HpaI and XhoI multicloning site was excised from pLentiLox3.7 
(Rubinson et al., 2003) and inserted 5’ of the Ubiquitin C promoter-GFP cassette in 
pFUGW.  siRNA sequences were selected using the siDESIGN program (Dharmacon, 
Inc.).  The siRNA used to knockdown BDNF was directed against the sequence:  5’- 
ggcactggaactcgcaatg-3’.  The control scrambled RNA was directed against the sequence: 
5’-ggatatgggctcactgaga-3’. Human wild-type dynamin, and a dominant-negative dynamin 
(K44A) were obtained from Dr. Sandra Schmid (Scripps Research Institute, La Jolla, 
CA) (Damke et al., 1994), and subcloned into lentivirus vector pFUGW-IRES-GFP (Lois 
et al., 2002) by PCR using the following primers: forward, 5-
cgcggatccgccgccaccatgggcaaccgcggcatgg-3 (with BamH I site); reverse, 5-
ccggaattcttagaggtcgaagggggg-3 (with EcoR I site).  All constructs were verified by DNA 
sequencing. Lentivirus was generated as described previously (Rubinson et al., 2003). 
Viral titers were determined by infection of HEK 293T cells (ATCC).  
Primary Granule Cell and Glia Cell Culture 
 
Primary cultures of granule cell precursors (GCPs) from P6 mouse cerebella were 
prepared as described previously (Choi et al., 2005; Klein et al., 2001). Briefly, cerebella 
were dissected and the pial layer was peeled away, the tissue was treated with trypsin and 
triturated into a single-cell suspension using a fine pipette tip. Cell suspension was passed 
through a cell strainer and underwent pre-plating twice for 30 min each in uncoated cell 
culture dishes before plating for migration assay or viral infection. When assessed by zic 
immunoreactivity, 94% of cells are of the granule cell lineage. Purified GCPs were plated 
for biochemical experiments in N2 medium [DMEM/F12 (1:1) medium containing N2 
supplement (Invitrogen), 24 mM KCl, 6 mg/ml glucose, 100 U/ml penicillin and 100 
µg/ml streptomycin] in 60mm cell culture dishes coated with 15 µg/ml poly-D-ornithine 
(Sigma) or in 35 mm tissue culture dish with agarose plug double coated with 15 µg/ml 
poly-ornithine and 20 µg/ml laminin (Invitrogen) for real-time migration assay. 
Pharmacological reagents were applied 30 min prior to BDNF treatment.  Glia cell 
purification and culture were carried out as described previously with some modifications 
(Borghesani et al., 2002; Edmondson and Hatten, 1987; Hatten, 1985). Briefly, 
dissociated cells from P6 mice were pre-plated into non-coated dish for 20 min to remove 
fibroblasts, then floating cells were plated into a new dish for 1 hour to allow glia 
attachment. Most adherent cells were glia cells. Purified glia cells were grown in DMEM 
medium with 10 % fetal bovine serum (FBS), 0.1% glucose, 2 mM L-glutamine, 100 
U/ml penicillin and 100 µg/ml streptomycin. For glia/granule cell co-cultures, 
subconfluent glia cell cultures were grown on laminin-coated coverslips for a day, then 
seeded with purified granule cell precursors on the second day at the ratio of 5-10 
neurons per glia cell. Co-cultures were grown for an additional day and treated with 
BDNF.  
 
Lentiviral Infection of Primary Cerebellar Granule Cells 
Dissociated GCPs from P4 mice were directly resuspended in virus-containing N2 
medium with 0.4 µg/ml poly-brene (Sigma), plated at high density (2-4 × 106 cell/ml) in 
an uncoated 6-well tissue culture plate overnight and then changed to fresh N2 medium 
supplemented with 2 ug/ml SHH. Forty eight hours later, aggregate cultures were 
dissociated with papain dissociation kit (Worthington Biochemical Co., Lakewood, New 
Jersey) according to the manufacturer’s instructions, then used for biochemical assays or 
real-time migration assay. Infection efficiency of GCPs with lentivirus is 80% on 
average, determined by the percentage of GFP-positive cells.   
 
Organotypic Slice Culture, BrdU Labeling, Viral Infection and Immunostaining 
 
Organotyptic cerebellar slices were prepared as described previously (Choi et al., 2005; 
Stoppini et al., 1991). Briefly, cerebella were dissected from P7 wild-type C57BL/6J 
pups and washed in calcium- and magnesium-free HBSS with 36 mM glucose and 15 
mM HEPES, pH 7.4. Cerebella were embedded in 2% low melting-point agarose in 
HBSS, and 250-µm-thick midsagittal slices were cut in an ice-cold HBSS bath using a 
vibrating microtome (VT1000S; Leica, Wetzlar, Germany). After removing the agarose 
gel, slices were transferred to a porous membrane insert (Millipore, Billerica, MA) with 
N2 medium in 6-well plates. Pharmacologic inhibitor was added to the medium 1 hour 
prior to BrdU labeling. BrdU was added to the medium for 2 hours, and slices were 
washed twice with fresh medium and cultured in complete medium containing half dose 
of pharmacologic inhibitor for 48 more hours. Slices were then fixed with 4% 
paraformaldehyde, and visualized with anti-BrdU as described (Choi et al., 2005). For 
viral infection, slices were immediately cultured in viral supernatant or concentrated 
virus-containing medium overnight on Millicel CM culture inserts, then transferred to N2 
medium and cultured for additional 72 hours. For experiments with bdnf siRNA 
lentivirus, the slices were pulse-labeled with BrdU for 6 hours after 24 hours of viral 
infection and then cultured an additional 36 hours before fixation. For experiments with 
Tiam1 siRNA lentivirus, pictures were taken with a Nikon Diaphot Inverted microscope. 
For experiments using dynamin-expressing lentivirus and bdnf siRNA lentivirus, slices 
were immunostained with anti-GFP after fixation and pictures were taken with Nikon 
Eclipse E800 microscope.  
 
Immunoprecipitations and Western Blot Analysis 
Immunoprecipitations were performed using lysates prepared from GCPs. Cells were 
lysed in RIPA lysis buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 1% Triton X-100, 
0.25% deoxycholic acid, 0.1% SDS, 1 mM Na3VO4, 10 mM NaF, 10 mM β-glycerol 
phosphate, and protease inhibitors [complete tablets; Roche]). Cell extracts were cleared 
by centrifugation for 10 min at 13000 rpm, and supernatants were aliquoted for 
incubation with primary antibody for 2 hours at 4 °C and then bound to Protein A/G 
Sepharose beads. Immunoprecipitates were washed four times with lysis buffer, separated 
by SDS-PAGE, transferred to PVDF membrane, immunoblotted with specific antibodies 
and developed using enhanced chemiluminescence (ECL) system (Amersham 
Biosciences). Densitometry of Western blot bands was carried out using the 
AlphaEase®FC software (Version 4.1.0, Alpha Innotech Co., CA), and the data were 
expressed as a percentage of the signals obtained under control condition. Unless 
otherwise indicated, all data of Western blot analyses are representative result from three 
independent experiments.  
 
Determination of BDNF Concentration  
 
The cerebellar IGL and EGL tissues from P7 mice were prepared from 250 µm-thick 
slices by microdissection. Tissues were lysed in RIPA lysis buffer and cleared by 
centrifugation. The protein concentration was titrated by Bradford assay (Bio-Rad). 
BDNF concentrations were determined with BDNF Emax® ImmunoAssay system 
(Promega) using 100 µg of total protein lysates according to manufacturer’s protocol. 
The final BDNF concentrations of EGL and IGL were calculated by subtracting out the 
signals obtained when we analyzed comparable lysates of EGL and IGL from bdnf -/- 
mice. The samples of culture medium for validation of BDNF gradient in real-time 
migration assay system was taken by multiple channel pipettor from three locations 
(8mm between each); the medium samples from NT4 treatment of cultured GCPs (total 4 
mL in each P60 dish coated with poly-D-ornithine and laminin) were collected and 
concentrated 10 fold with Amicon® Ultra centrfugal filter devices Amicon Ultra-4 
(Millipore). The BDNF concentration was determined by ELISA.  
 
Rac1, cdc42, RhoA Activation Assay and Evaluation of Surface TrkB 
Internalization 
 
TrkB internalization was evaluated by biotinylation of surface TrkB.  Dissociated GCPs 
were treated with or without 50ng/ml BDNF for indicated times. Cells were then washed 
3 times with ice-cold PBS (pH7.4) and biotinylated with 400 µg/ml EZ-Link® Sulfo-
NHS-biotin (Pierce) in PBS at 4°C for 30 min. Cells were washed 4 times with ice-cold 
PBS and lysed in RIPA buffer.  The remaining, biotinylated surface proteins were 
precipitated by immobilized streptavidin (Amersham Biosciences), separated by SDS-
PAGE, and subjected to Western blot using monoclonal anti-TrkB antibody. Cells were 
incubated with the inhibitor for 30 min prior to BDNF treatment.  Densitometry analysis 
of Western blot bands was carried out as described above. The data were expressed as a 
percentage of the signals obtained under the condition at time point 0. 
           Rac1 and cdc42 activation were assessed by GST-PBD pull-down assay kit (UBI) 
and RhoA activation was measured by GST-RBD pull-down assay kit (UBI) according to 
manufacturer’s instruction. Briefly, GCPs were treated with 50 ng/ml BDNF for 5 min 
and lysed with lysis buffer. Cell extracts were incubated with 25 µg/tube of PBD or RBD 
resin for 45 min at 4°C. Pellets were washed three times, and analyzed by Western 
blotting with Rac1, cdc42 or RhoA-specific antibody. 
 
Immunocytochemistry, Immunohistochemistry and Image Analysis 
 
Dissociated GCPs were exposed to a BDNF gradient for 12 hours and then fixed in 4% 
paraformaldehyde in Tris-HCl-buffered saline (TBS) for 20 min, permeabilized in 0.1% 
Triton X-100 in TBS for 10 min, blocked with 5% goat serum in TBS for 1 hour, and 
then probed with primary antibodies diluted in blocking solution.  Primary antibodies 
were detected using goat anti-mouse or goat anti-rabbit Ig conjugated with Alexa® 488 or 
Alexa® 546 (Molecular Probes), and samples were mounted in Vectashield (Vector 
Laboratories). For glia/granule cell co-cultures, cells on the coverslip were treated with or 
without 10 ng/ml BDNF for 1 hour and fixed as described above. Cerebella from P6 bdnf 
+/+ or -/- pups (six animals each) were fixed with 4% paraformaldehyde for 24 hours 
and processed as described previously (Carter et al., 2003). Ten µm cryostat sections 
were immunostained with antibodies as indicated.  Images were captured with Zeiss 
Delta vision microscope, using a 100 × objective with sequential acquisition settings at 
1024 × 1024 pixel resolution. A Z series of ten optical sections, 0.4 µm/section, was 
obtained and analyzed by Adobe Photoshop 7.0 after deconvolution. For quantification of 
co-localization analysis, the images of inner EGL from wild type and mutant sections 
were chosen to be analyzed for co-localization of signaling molecules using Volocity 
software (version 3.7.0, 2006, Improvision Ltd.). 
 
Real-time Migration Assay 
 
GCPs were prepared and plated as described above. Four hours after plating, a gradient of 
BDNF was created by loading 2 µg of BDNF to 50 µl of 1% agarose gel (Invitrogen) 
glued to one side of the 35 mm tissue culture dish (see Figure 1B). After plating, cells 
were observed under an inverted microscope Zeiss Axiovert 200 M, in bright field, and 
images were captured using a Photometrics CoolSNAP HQ digital camera controlled by 
Slidebook software (Intelligent Imaging Innovations, Inc). For assays using a source of 
BDNF in the agarose, the dishes were incubated for 4 hours at 37oC to allow diffusion of 
BDNF. One field close to the agarose was selected for observation and pictures were 
taken every 2 min during 2 hours. The pictures were then transferred to Adobe 
Photoshop, and the total number of cells and number of migrating cells were determined. 
The parameters measured were the following: 1) percentage of cells that migrate; 2) 
speed of migration (µm/h); and 3) direction of migration, classified as toward or away 
from the BDNF source. 
             On Adobe Photoshop 7.0, individual images were compiled as layers, the 
movement of single granule cells was traced, and the parameters of cell speed (µm/hour) 
and direction (toward or away from the plug) were determined. To compute the 
percentage of cells that migrate, the number of migrating granule cells was divided by the 
total isolated granule cells (both migrating and non-migrating) in the field and multiplied 
by 100. In each experiment, the percentage obtained from the condition without BDNF 
was assigned a value of 100% and all other conditions (i.e. gradient BDNF and uniform 
BDNF) were measured relative to this basal condition. To calculate the percentage of 
cells migrating toward versus away from the BDNF source, all cells that migrated in the 
upward direction relative to the horizontal (pictures were taken such that the agarose plug 
was at the top of the field) were counted as migrating “toward” whereas any cells that 
moved in the downward direction were counted as “away.”  Because the BDNF-
containing plug is smaller than the width of the microscope field, cells migrating toward 
the source appear to travel at an angle of 0-45 degrees relative to the y- axis, and so 
further parsing of directionality is not helpful.   
To calculate standard errors in results pooled from multiple experiments (each 
graph represents the mean of 3-4 individual experiments) we used two methods.  In the 
first method, for each individual experiment we normalized the percent of migrating cells 
and the percent of cells migrating toward or away under each condition to the values 
obtained in that experiment with no BDNF and no other intervention.  Thus, control 
values are 100% by definition.  Standard deviations for migration were calculated for 
each condition, and used to generate standard error of the mean.  When we compare 
migration in cells from mutant and wild type animals, where there are two distinct cell 
preparations in each experiment, we calculated standard deviation by designating the 
migratory index of each cell as 0 for a non-migrating cell, and 1 for a migrating cell.  
Standard deviations and standard errors for migratory indices of the cells from all three 
experiments were then calculated for each condition. 
  Calculations for the random migration coefficient (µ) were based on the 
algorithm presented by Shreiber and colleagues (Shreiber et al., 2003). To quantify cell 
migration, the mean-squared displacement <d2(t)> is calculated from position data over 
all experimental time, ultimately yielding a single value for the random cell migration 
coefficient µ, that describes the average migration of the population of cells over the 
duration of the experiment. Then, <d2(t)>  is fit to a persistent random walk model with a 
GLSR algorithm. Any cell that moved faster than 150 µm/hour was excluded because it 
was presumed to be a dead or floating cell.  
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Supplemental Figure 1.  A Gradient of BDNF Is Formed in vitro and in vivo.  
 
(A)  A BDNF gradient forms in the developing cerebellum.  BDNF concentrations 
in lysates of the EGL and the IGL were analyzed in BDNF wild type and mutant 
mice (P7) by ELISA.  The results shown represent the means + SEM (n=3). The 
concentration of BDNF in 100 µg of total protein lysates was determined and 
used to calculate pg/ml/µg protein. A cerebellar lysate contains 1.5 mg protein 
from a cerebellum occupying 20 µm3. 
(B) Schematic of in vitro real-time migration assay system. 
(C) A gradient of BDNF is created by diffusion of BDNF from an agarose plug into 
the medium.  A representative result of three independent experiments 
documents the BDNF gradient formed over time. BDNF concentrations were 
determined at three different locations in the assay system at 0, 4, 6 and 24 
hours.  
 
 Supplemental Figure 2. BDNF Does Not Affect the Speed of GCP Movement.  Real-
time migration assay was carried out as described in Figure 1. The speed of GCP 
migration (µm/hour) was calculated from four independent experiments under three 
conditions (no BDNF, gradient and uniform BDNF, respectively). Data shown represent 
means + SEM (n=4). 
 
 
 
 
 
 
 
 
 
 
 
 Supplemental Figure 3.  Erk Pathway Is Not Required for BDNF-induced GCP 
Migration.  
(A) U0126, a MEK inhibitor, does not block BDNF-induced GCP migration. 
GCP real-time migration was analyzed from three independent experiments 
in the absence or presence of U0126 (10 nM). Data were evaluated by z test 
(*, p < 0.005) and by two-tailed student t-test (**, p<0.05), respectively. 
(B) Validation of the effect of U0126 treatment on BDNF-induced TrkB 
signaling. Western blot analyses show that U0126 treatment (10 nM) 
specifically and efficiently inhibits BDNF-induced activation of Erk pathway 
in GCPs. Dissociated GCPs were pre-treated with vehicle or inhibitor for 30 
min prior to BDNF addition.   
 
 
 
 
